MedTrace Logo

A Prospective, Randomized, Double-blinded, Controlled, Split-face, Non-inferiority Clinical Investigation Comparing the Safety and Performance of RefillHA Solid With Hydryalix Ultra Deep Lidocaine for the Correction of Moderate-to-severe Nasolabial Folds.

NCT07736703 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2026-07-30

No results posted yet for this study

Summary

Prospective, controlled, randomized, monocentric, double-blind, split-face non-inferiority clinical study to evaluate the safety and performance of injectable implant based on hyaluronic acid hydrogel with lidocaine for correction of moderate-to-severe nasolabial folds

Conditions

  • Wrinkles and Folds

Sponsors & Collaborators

  • Glyance

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-08
Primary Completion
2026-01-25
Completion
2026-01-25

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07736703 on ClinicalTrials.gov